Home Stocks Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd

The live share price of Sun Pharmaceutical Industries Ltd (SUNPHARMA) as on 19 Apr 10:26am is ₹1,522.8 from NSE/BSE.

SUNPHARMA NSE

₹1,522.8 ▲0.42% (6.4)

As on Apr 19, 2024 03:56 PM IST

How do you feel today about Sun Pharmaceutical Industries Ltd?

Bearish or

Bullish

Bearish or

Bullish

Key Metrics

PE Ratio

41.02

PB Ratio

6.16

Dividend Yield

0.76%

Sector PB

5.82

Sector PE

51.18

Sector Div Yld

0.57%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Largecap, ₹3,65,370 Cr

Sun Pharmaceutical Industries Limited is a pharmaceuticals company which offers generics, branded generics, specialty products, over-the-counter products, anti-retroviral and APIs.

The following charts display the financial performance of the Sun Pharmaceutical Industries Ltd (SUNPHARMA) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Sun Pharmaceutical Industries Ltd (SUNPHARMA), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Largecap, ₹3,65,370 Cr

Financials

Income Statement

(INR)		Y/Y Change
Revenue	44,394 Cr	+11.74%
Operating Expense	2,326 Cr	-67.45%
Net Income	8,473 Cr	+158.91%
Net Profit Margin	19.09%	+131.67%
Earning Per Share	35	+158.94%
EBITDA	12,109 Cr	+79.34%

Balance sheet

(INR)		Y/Y Change
Cash & short-term Inv	15,142 Cr	+19.54%
Total Assets	80,711 Cr	+15.67%
Total Liabilities	21,396 Cr	+14.36%
Total Equity	59,315 Cr	+16.15%
Shares Outstanding	239.93 Cr	-
Price to Book	3.98	-6.78%
Return on Assets	11.26%	+136.55%
Return on Capital	16.15 Cr	+79.05%

Cash Flows

(INR)		Y/Y Change
Net Income	8,473 Cr	+158.91%
Cash from Operations	4,959 Cr	-44.8%
Cash from Investing	-7,219 Cr	+29.95%
Cash from Financing	2,376 Cr	-145.75%
Net Change in Cash	115 Cr	-106.54%
Free Cash Flow	2,873 Cr	-61.63%

Shareholding Pattern

Total Promoter Holding

54.48%

Unpledged

Foreign Institutions

17.72%

Foreign Institutions

Retail & Others

8.98%

Retail & Others

Other Parties

Other Domestic Institutions

6.61%

Insurance Firms

Others

Mutual Funds

12.21%

Mutual Funds

Peers

CIPLA

Cipla Ltd

PE Ratio

29.3

1Y Return

▲47.58%

DRREDDY

Dr Reddy's Laboratories Ltd

PE Ratio

18.93

1Y Return

▲21.05%

MANKIND

Mankind Pharma Ltd

PE Ratio

54.22

1Y Return

▲64.34%

ZYDUSLIFE

Zydus Lifesciences Ltd

PE Ratio

31.2

1Y Return

▲78.33%

Latest News

Sun Pharma-FDA: Regulatory Concerns At Dadra facility Can Dent Sentiment, Say Analysts

2 days ago on Bloomberg Quint

Change since news ▼-INF%

Analysts say that the FDA action at the Dadra unit can push Sun Pharma’s stock into a price-wise corrective phase.

Brokerage Views: Citi On Delhivery, Vodaone Idea, HSBC On Sun Pharma And More

5 days ago on Bloomberg Quint

Change since news ▼-INF%

NDTV Profit is tracking what the brokerages are putting out on specific stocks.

Another regulatory blow for Sun Pharma after Dadra unit tagged ‘OAI’ by US FDA, stock down

5 days ago on Moneycontrol

Change since news ▼-INF%

The official action indicated classification for the Dadra unit by FDA follows similar trouble at Sun Pharma’s Halol and Mohali facilities recently, which hit generic sales

FAQs on Sun Pharmaceutical Industries Ltd

How to buy Sun Pharmaceutical Industries Ltd stocks?

You can easily buy the stocks/shares of Sun Pharmaceutical Industries Ltd (SUNPHARMA) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Sun Pharmaceutical Industries Ltd?

The stock price of Sun Pharmaceutical Industries Ltd as on 19 Apr 2024 is ₹1,522.8

What is the 52-week High and Low of Sun Pharmaceutical Industries Ltd?

The 52-week high and low of Sun Pharmaceutical Industries Ltd (SUNPHARMA) is ₹1,638.85 and ₹922.45.

What is the PE and PB ratio of Sun Pharmaceutical Industries Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Sun Pharmaceutical Industries Ltd are 41.02 and 6.16 respectively.

What are the peers or stocks similar to Sun Pharmaceutical Industries Ltd?

The peers or stocks similar to Sun Pharmaceutical Industries Ltd are Cipla Ltd, Dr Reddy's Laboratories Ltd, Mankind Pharma Ltd, Zydus Lifesciences Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Sun Pharmaceutical Industries Ltd belong to?

Sun Pharmaceutical Industries Ltd (SUNPHARMA) belongs to the Pharmaceuticals sector.

What is the Market Cap of Sun Pharmaceutical Industries Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sun Pharmaceutical Industries Ltd (SUNPHARMA) is ₹3,65,370 Cr as of 19 Apr 2024

Can't decide whether or not to buy Sun Pharmaceutical Industries Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.

Dislaimer: This platform is intended for informational purposes only and is not intended to provide investment advice. The stock prices displayed are delayed and may not reflect the most current market conditions. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. You can also consider consulting a financial advisor before making any investment decisions. Smallcase Technologies Private Limited shall not be responsible for any losses that may occur as a result of using this platform.